Model Number 1804350-15 |
Device Problem
Material Rupture (1546)
|
Patient Problems
Air Embolism (1697); Ischemia (1942)
|
Event Date 01/08/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
The stent remains in patient.The device will not be returned for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
|
|
Event Description
|
It was reported that the procedure was to treat a left anterior descending (lad) artery that is 90% stenosed.After pre-dilatation was performed with an unspecified balloon dilatation catheter the 3.5x15mm xience skypoint stent delivery system (sds) was delivered and was inflated to 12 atmospheres; however, the balloon ruptured.Contrast medium flowed to the distal lad and air leaked at the same time causing a slow-flow.Nitroglycerin was administered and the blood flow stabilized.The stent was expanded properly with the kissing balloon technique to fully appose the stent into the vessel wall.There was no clinically significant delay reported.The physician¿s opinion was that this was a xience skypoint related interaction since there was no calcification in the lesion and there was no problem with the pre-dilatation.Prior to use, the catheter was soaked in saline.The device was prepped (air aspiration) outside the anatomy.No resistance was met when the protective sheath was removed.No resistance was met during advancement or removal.No additional information was provided.
|
|
Manufacturer Narrative
|
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.The reported patient effects of ischemia and embolism (air) are listed in the xience skypoint everolimus eluting coronary stent systems instructions for use (iuf) as known patient effects of coronary stenting procedures.The investigation was unable to determine a conclusive cause for the reported material rupture.The patient effects and treatment appear to be related to operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
|
Search Alerts/Recalls
|